E. T. Elkiran Et Al. , "The effect of front-line chemotherapy on overall survival in patients with malignant pleural mesothelioma.," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , vol.31, Illinois, United States Of America, 2013
Elkiran, E. T. Et Al. 2013. The effect of front-line chemotherapy on overall survival in patients with malignant pleural mesothelioma.. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).
Elkiran, E. T., Sevinc, A., & Harputluoglu, H., (2013). The effect of front-line chemotherapy on overall survival in patients with malignant pleural mesothelioma. . Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America
Elkiran, Emin, Alper Sevinc, And HAKAN HARPUTLUOĞLU. "The effect of front-line chemotherapy on overall survival in patients with malignant pleural mesothelioma.," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2013
Elkiran, Emin T. Et Al. "The effect of front-line chemotherapy on overall survival in patients with malignant pleural mesothelioma.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2013
Elkiran, E. T. Sevinc, A. And Harputluoglu, H. (2013) . "The effect of front-line chemotherapy on overall survival in patients with malignant pleural mesothelioma.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Emin Tamer Elkiran Et Al. }, title={The effect of front-line chemotherapy on overall survival in patients with malignant pleural mesothelioma.}, congress name={Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2013}}